VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Clinical trial NCT03148132 · COMPLETED

Trial details

NCT number: NCT03148132
Sponsor: Universidad Autonoma de San Luis Potosí
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Retinopathy of Prematurity Both Eyes Retinal Disease Premature Birth Eye Diseases

Start date: 2017-05-23
Primary completion: 2018-08-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.